FDA Inspection 754638 — Opella Healthcare International SAS
The FDA completed an inspection of Opella Healthcare International SAS on October 21, 2011 in Compiegne. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 21, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Compiegne (France)